NCT02605811 Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT02593019 Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients Status COMPLETED Phase PHASE2
NCT02577627 Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC Status UNKNOWN Phase N/A
NCT02551432 Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT02514447 Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy Status COMPLETED Phase PHASE1/PHASE2
NCT02500914 SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma Status TERMINATED Phase PHASE1
NCT02499770 Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT02446704 Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy Status UNKNOWN Phase PHASE1/PHASE2
NCT02425072 NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02391480 A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer Status COMPLETED Phase PHASE1
NCT02367352 Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT02349412 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers Status COMPLETED Phase PHASE3
NCT02348450 Irinotecan Plus Cisplatin Compared With Etoposide Plus Cisplatin for Extensive Stage Small-cell Lung Cancer Status UNKNOWN Phase PHASE4
NCT02337712 Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT02331251 Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus) Status TERMINATED Phase PHASE1/PHASE2
NCT02324296 PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases Status COMPLETED Phase N/A
NCT02297087 Next-generation Sequencing of Small Cell Lung Cancer to Identify Actionable Targets for Treatment Status TERMINATED Phase NA
NCT02289690 Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02273336 Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer Status COMPLETED Phase N/A